Search

OPINION – Cosmetic surgery: a difficult reality with a simple solution

On 1 September 2022, an Independent Review released its long-awaited Report into Cosmetic Surgery in Australia [1]. Its key recommendation reflected the sentiment of our new, peer-reviewed, paper in the American Journal of Cosmetic Surgery entitled ‘Cosmetic Surgery Regulation in...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...